288 related articles for article (PubMed ID: 38629065)
21. Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors.
Meurgey A; Girard N; Merveilleux du Vignaux C; Maury JM; Tronc F; Thivolet-Bejui F; Chalabreysse L
J Thorac Oncol; 2017 Oct; 12(10):1571-1581. PubMed ID: 28694035
[TBL] [Abstract][Full Text] [Related]
22. Understanding the landscape of immunotherapy in thymic epithelial tumors.
Maniar R; Loehrer PJ
Cancer; 2023 Apr; 129(8):1162-1172. PubMed ID: 36808725
[TBL] [Abstract][Full Text] [Related]
23. Thymic Epithelial Tumor and Immune System: The Role of Immunotherapy.
Perrino M; Cordua N; De Vincenzo F; Borea F; Aliprandi M; Cecchi LG; Fazio R; Airoldi M; Santoro A; Zucali PA
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067278
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic autoimmunity in thymus tumors.
Marx A; Schultz A; Wilisch A; Helmreich M; Nenninger R; Müller-Hermelink HK
Dev Immunol; 1998; 6(1-2):129-40. PubMed ID: 9716914
[TBL] [Abstract][Full Text] [Related]
25. Pathomechanisms of paraneoplastic myasthenia gravis.
Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
[TBL] [Abstract][Full Text] [Related]
26. A striational muscle antigen and myasthenia gravis-associated thymomas share an acetylcholine-receptor epitope.
Marx A; Osborn M; Tzartos S; Geuder KI; Schalke B; Nix W; Kirchner T; Müller-Hermelink HK
Dev Immunol; 1992; 2(2):77-84. PubMed ID: 1379503
[TBL] [Abstract][Full Text] [Related]
27. Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: Clinicopathological features and quantitative digital image analyses.
Ishihara S; Okada S; Ogi H; Kodama Y; Shimomura M; Tsunezuka H; Itoh K; Marx A; Inoue M
Lung Cancer; 2020 Jul; 145():40-47. PubMed ID: 32402921
[TBL] [Abstract][Full Text] [Related]
28. Narrative review of immunotherapy in thymic malignancies.
Benitez JC; Besse B
Transl Lung Cancer Res; 2021 Jun; 10(6):3001-3013. PubMed ID: 34295693
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric study of lymphocytes associated with thymoma and other thymic tumors.
Fujii Y; Okumura M; Yamamoto S
J Surg Res; 1999 Apr; 82(2):312-8. PubMed ID: 10090845
[TBL] [Abstract][Full Text] [Related]
30. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
Ströbel P; Murumägi A; Klein R; Luster M; Lahti M; Krohn K; Schalke B; Nix W; Gold R; Rieckmann P; Toyka K; Burek C; Rosenwald A; Müller-Hermelink HK; Pujoll-Borrell R; Meager A; Willcox N; Peterson P; Marx A
J Pathol; 2007 Apr; 211(5):563-571. PubMed ID: 17334980
[TBL] [Abstract][Full Text] [Related]
31. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
[TBL] [Abstract][Full Text] [Related]
32. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.
Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S
Front Oncol; 2021; 11():647512. PubMed ID: 34568003
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathological aspects of thymic epithelial tumors.
Okumura M; Shiono H; Minami M; Inoue M; Utsumi T; Kadota Y; Sawa Y
Gen Thorac Cardiovasc Surg; 2008 Jan; 56(1):10-6. PubMed ID: 18213465
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
[TBL] [Abstract][Full Text] [Related]
35. Thymic Lesions in Myasthenia Gravis: A Clinicopathological Study from India.
Nishadham V; Bardhan M; Polavarapu K; Vengalil S; Nashi S; Menon D; Ganaraja VH; Preethish-Kumar V; Valasani RK; Huddar A; Unnikrishnan GK; Thomas A; Saravanan A; Kulanthaivelu K; Nalini A; Nandeesh BN
J Neuromuscul Dis; 2022; 9(3):411-422. PubMed ID: 35431258
[TBL] [Abstract][Full Text] [Related]
36. Postoperative clinical outcomes of patients with thymic epithelial tumors after over-3-year follow-up at a single-center.
Jiao P; Tian WX; Wu FJ; Liu YX; Wu JY; Sun YG; Yu HB; Huang C; Wu QJ; Ma C; Li DH; Tong HF; Li J
J Cardiothorac Surg; 2023 Feb; 18(1):77. PubMed ID: 36810094
[TBL] [Abstract][Full Text] [Related]
37. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
[TBL] [Abstract][Full Text] [Related]
38. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
Chan JK; Tsang WY; Seneviratne S; Pau MY
Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
[TBL] [Abstract][Full Text] [Related]
39. Immune checkpoints in thymic epithelial tumors: challenges and opportunities.
Girard N
Immunooncol Technol; 2019 Oct; 3():8-14. PubMed ID: 35757304
[TBL] [Abstract][Full Text] [Related]
40. [Expression of CD20 in thymomas and its clinical implication].
Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
